← All companies
Generate ideas →
Coral Genomics
AcquiredNew clinical tests for managing autoimmune treatments.
Summer 2018Founded 20185 peopleSan Francisco, CA, USA
↻ Pivot / rename signal
This company has previously operated under “WeSeq”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Founders · 2
Jacob BorrajoFounder
Related startups
Cofactor GenomicsSummer 2015
Cofactor closes the precision medicine gap with predictive diagnostics
Active
Cambridge Cancer GenomicsSummer 2017
CCG.ai empowers clinicians to make personalised treatment strategies…
Inactive
